All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Does President Donald Trump's extensive conversation with the CEO of Pfizer Inc. to get the company to hold off on midyear list price increases constitute government interference with prescription drug prices?